Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm, Residual × Mercaptopurine × Clear all

Phase

Phase 4 3 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Leukemia 28 Burkitt Lymphoma 13 Leukemia, Biphenotypic, Acute 7 Lymphoma 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Promyelocytic, Acute 2 Down Syndrome 2 Thrombocytopenia 1 Rare Diseases 1 Philadelphia Chromosome 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neutropenia 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Glioma 1 Glioblastoma 1

Interventions

blinatumomab 9 Cyclophosphamide 7 Rituximab 6 Lenalidomide 6 Dexamethasone 5 Azacitidine 5 venetoclax 4 fludarabine 4 Cytarabine 4 fludarabine phosphate 3 Busulfan 3 tislelizumab 2 thymoglobulin 2 pembrolizumab 2 obinutuzumab 2 daratumumab 2 Whole-Body Irradiation 2 N,N-dicyclohexyl-isoborneol-10-sulfonamide 2 Methotrexate 2 Melphalan 2 Maintenance 2 Immunotherapy 2 Imatinib Mesylate 2 Drug Therapy 2 Docetaxel 2 Decitabine 2 Clofarabine 2 Cladribine 2 Carboplatin 2 Calcium Dobesilate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02067143 2021-09-08

LAL1913

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Completed

Neoplasm Metastasis, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡